Allergy to betalactam antibiotics in children: A prospective follow-up study in retreated children after negative responses in skin and challenge tests

Hôpital du Jura, Pruntrut, Jura, Switzerland
Allergy (Impact Factor: 6.03). 02/2007; 62(1):42-6. DOI: 10.1111/j.1398-9995.2006.01246.x
Source: PubMed


Up to 10% of the patients in whom suspected betalactam hypersensitivity (HS) has been excluded by skin and challenge tests report suspected allergic reactions during subsequent treatments with the same or very similar betalactams. It has been suggested that the reactions may result from a resensitization induced by the challenge performed at the time of the allergological work-up. However, most patients did not undergo a second allergological work-up, to determine if the reactions resulted from betalactam HS or not.
We aimed to determine if children diagnosed nonallergic to betalactams have tolerated subsequent treatments with the initially suspected and/or other betalactams, and, in case of a reaction, if the reaction resulted from betalactam HS. Methods: We sent a questionnaire concerning the clinical history of their children to the parents of 256 children previously diagnosed nonallergic to betalactams. A second allergological work-up was performed in the children reporting suspected allergic reactions during subsequent treatments with the same and/or other betalactams. Skin tests were performed with the soluble form of the suspected (or very similar) betalactams and other betalactams from the same and other classes. Skin test responses were assessed at 15-20 min (immediate), 6-8 h (semi-late) and 48-72 h (late). Oral challenge (OC) was performed in children with negative skin tests, either at the hospital (immediate and accelerated reactions), or at home (delayed reactions).
A response was obtained from 141 children (55.3%). Forty-eight (34%) of those children had not been treated with the betalactams for whom a diagnosis of allergy had been ruled out previously. Seven (7.5%) of the 93 children who had been treated again reported suspected allergic reactions. Skin tests and OC were performed in six of those children, and gave negative results in five children. In one child previously diagnosed nonallergic to amoxicillin associated with clavulanic acid, we diagnosed a delayed HS to clavulanic acid and a serum sickness-like disease to cefaclor. Thus, the frequency of reactions resulting from betalactam HS in children with negative skin and challenge tests is very low, and does not exceed 2.1% (2/93) if we consider that the child which refused a second allergological work-up is really allergic to betalactams.
Our results in a very large number of children show that reactions presumed to result from betalactam HS are rare in children in whom the diagnosis of betalactam allergy has been ruled out previously. Moreover, they suggest that, as shown for the initial reactions, most of the reactions during subsequent treatments are rather a consequence of the infectious diseases for whom betalactams have been prescribed than a result of betalactam HS. Finally, they suggest that the risk of resensitization by OC is very low, and do not support the notion that skin testing should be repeated in children diagnosed nonallergic to betalactams.

Download full-text


Available from: Claude Ponvert, Sep 21, 2014
  • Source
    • "Studies regarding the NPV of DPTs are encouraging. A high NPV of beta-lactam DPT of 94-98% was found in large studies involving 256 children [30] and 457 patients (both adults and children) [31] and most of the reactions reported by patients were mild non-immediate reactions. As for the antibiotics, the NPV of DPTs with NSAIDs appears to be also high (over 96%) whatever the NSAID (the one negatively tested or an alternative), and none of the false-negative patients described a life-threatening reaction [31]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug provocation tests (DPTs) are often needed when evaluating patients with suspected drug hypersensitivity reactions. General considerations on DPTs, with regard to indications, contraindications, methods, limitations and interpretations have been thoroughly addressed and various protocols are published. However, the field of drug allergy is changing and DPTs make no exception. Novel (or sometimes, simply renewed) approaches arise, awaiting to be either validated or refuted in larger studies in the future. Instead of covering the whole topic of DPTs, this paper will address these recent and challenging aspects.
    Full-text · Article · Apr 2013 · Allergy Asthma and Clinical Immunology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Individual approaches to the diagnosis and management of penicillin allergy are practiced by clinicians. This cross-sectional survey of physicians was aimed at exploring their ways of dealing with diagnosis and management of penicillin G allergy. Of the 235 respondents, 63% believed patients' self-reported history of penicillin allergy and avoided using penicillin G; 97% do so for patients whose allergic status was confirmed with positive skin test results. Researchers insist on skin testing for patients claiming penicillin allergy and for those whose allergic status was confirmed with positive skin test results, before considering antibiotic substitution, in an attempt to minimize the development of multi drug resistant pathogens. Undue concern about penicillin allergy may negatively influence the therapeutic outcome of rheumatic fever and syphilis. Repeated skin testing is recommended before each subsequent course of penicillin G, even in patients who have tolerated it before which was practiced by an appreciable number (89%) of our respondents. Epi cutaneous followed by intra dermal routes with major and minor determinants have been recommended for penicillin G skin testing. 100% of our respondents skin tested by intra dermal route alone, using penicillin G and its repository preparations before injecting the respective full dose preparations. Legal problems arising from serious clinical outcomes of penicillin allergy may pose a threat to the physician of losing self esteem in the society forcing him to be overcautious with its use. Educating both the public and health care providers is necessary in this regard.
    Full-text · Article · Jan 2008 · Iranian Journal of Pharmacology and Therapeutics
  • [Show abstract] [Hide abstract]
    ABSTRACT: The control of industrial robots is usually divided into several sequential stages. Trajectory planning is an important off-line stage which is concerned with the generation of a time history of a robot's joint position, velocity, acceleration, and input torques. A number of trajectory planning methods have been developed [1], [4]-[6], [10], [11], [13], which usually entail complex computations and algebraic manipulations. Programming this sort of trajectory planners is very complex and error-prone, thereby limiting their applicability. To remove this limitation, we have begun the development of software for automating the trajectory planning, called the Automatic Trajectory Planner Generator (ATPG). This paper describes important components of the ATPG: three trajectory planners, data structures for describing geometric paths, generation of the robot's dynamic equations and constraint functions, and ancillary software. A large portion of the ATPG has been completed, and the remaining portion is currently under development.
    No preview · Conference Paper · May 1986
Show more